PDCD1 and metastatic melanoma: Genetic analysis of SNPs have linked a variant (rs17388568) associated with increased risk of ulcerative colitis [61] and type 1 diabetes [62] with an enhanced response to anti-PD-1 in metastatic melanoma patients [63].